Cover Image

How inflated published prices affect drugs considered for the federal upper limit list.

Bibliographic Details
Corporate Author:	United States. Department of Health and Human Services. Office of Inspector General (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2005.
Subjects:	Medicaid. Drugs > Prices > United States. Centers for Medicare & Medicaid Services (U.S.) > Rules and practice. Pharmaceutical services insurance > United States. Pharmaceutical policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo69190

Similar Items

Comparison of Medicaid federal upper limit amounts to average manufacturer prices.
Published: (2005)

Addition of qualified drugs to the Medicaid federal upper limit list.
Published: (2004)

Omission of drugs from the federal upper limit list in 2001.
Published: (2004)

Variation in state Medicaid drug prices.
Published: (2004)

Medicaid drug price comparisons : average sales price to average wholesale price.
Published: (2005)

Medicaid drug price comparisons : average manufacturer price to published prices.
Published: (2005)

Comparing pharmacy reimbursement : Medicare Part D to Medicaid.
Published: (2009)

Medicaid's use of revised average wholesale prices.
Published: (2001)

The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)

Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)

What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2018)

Qué hacer si ya no califica automáticamente para la Ayuda Adicional con los costos de la cobertura de recetas médicas de Medicare.
Published: (2018)

What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs.
Published: (2017)

Experiences of health maintenance organizations with pharmacy benefit management companies.
Published: (1997)

Generic drug utilization in state Medicaid programs.
Published: (2006)

Replacing average wholesale price : Medicaid drug payment policy.
Published: (2011)

Medicaid rebates for physician-administered drugs.
Published: (2004)

Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)

Deficiencies in the oversight of the 340B drug pricing program.
Published: (2005)

Deficiencies in the 340B drug discount program's database.
Published: (2004)

States' use of new drug pricing data in the Medicaid program.
Published: (2007)

Early implementation of MMA : status report of the state health insurance assistance programs /
Published: (2006)

States' collection of Medicaid rebates for physician-administered drugs.
Published: (2011)

States' collection of rebates for drugs paid through Medicaid managed care organizations.
Published: (2012)

Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D.
Published: (2011)

Medicare reimbursement for lupron.
Published: (2004)

Medicaid brand-name drugs : rising prices are offset by manufacturer rebates.
Published: (2011)

CMS's implementation of safeguards during fiscal year 2006 to prevent and detect fraud and abuse in Medicare prescription drug plans.
Published: (2007)

Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)

Medicare and Medicaid Program Integrity : Combating Improper Payments and Ineligible Providers.
Published: (2016)

Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010.
Published: (2010)

Medicare drug plan sponsors' identification of potential fraud and abuse.
Published: (2008)

Medicare prescription drug coverage : how to join a Medicare drug plan.
Published: (2010)

Medicaid recovery of pharmacy payments from liable third parties.
Published: (2001)

Update : excessive Medicare reimbursement for albuterol.
Published: (2004)

1999 Medicare and Medicaid benefits.
Published: (1999)

Effect of the Part D coverage gap on Medicare beneficiaries without financial assistance in 2006.
Published: (2009)

Update : excessive Medicare reimbursement for ipratropium bromide.
Published: (2004)

Excessive Medicare reimbursement for ipratropium bromide.
Published: (2002)

Medicare reimbursement for new end stage renal disease drugs.
Published: (2006)